Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4106140 Target Snapshot

METTL3/METTL14 · PROTEIN COMPLEX · Homo sapiens

241Compounds
37Assays
2Approved Drugs
237.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q86U44. Use UniProt Q86U44 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q86U44 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Protein anchor
N(6)-adenosine-methyltransferase catalytic subunit METTL3

N(6)-adenosine-methyltransferase catalytic subunit METTL3

Review this target as METTL3/METTL14, mapped to UniProt Q86U44. ChEMBL maps the protein component as N(6)-adenosine-methyltransferase catalytic subunit METTL3. Sequence length is 580 aa.

Protein source · UniProt accession via ChEMBL component mapping
UniProt Q86U44 Protein 580 aa
Open protein block
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats METTL3/METTL14 as ChEMBL target CHEMBL4106140, mapped to UniProt Q86U44. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
METTL3/METTL14
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4106140
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q86U44
N(6)-adenosine-methyltransferase catalytic subunit METTL3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether METTL3/METTL14 is the right protein anchor across sources, using UniProt Q86U44 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelN(6)-adenosine-methyltransferase catalytic subunit METTL3
UniProt AccessionQ86U44
Component TypeProtein
Sequence Length580 aa

N(6)-adenosine-methyltransferase catalytic subunit METTL3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as METTL3/METTL14, mapped to UniProt Q86U44. ChEMBL maps the protein component as N(6)-adenosine-methyltransferase catalytic subunit METTL3. Sequence length is 580 aa.

Mapped IDQ86U44
Review nameMETTL3/METTL14
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC50234.0
KD3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5291234 8.85 Kd 1.4 Preclinical
CHEMBL5396973 8.44 IC50 3.63 Preclinical
CHEMBL5076382 8.42 IC50 3.84 Preclinical
CHEMBL5405105 8.36 IC50 4.35 Preclinical
CHEMBL5071936 8.21 IC50 6.1 Preclinical
CHEMBL5072426 8.21 IC50 6.1 Preclinical
CHEMBL5074655 8.21 IC50 6.1 Preclinical
CHEMBL5075067 8.21 IC50 6.1 Preclinical
CHEMBL5075128 8.21 IC50 6.1 Preclinical
CHEMBL5075825 8.21 IC50 6.1 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
13
5.5
10
6.0
17
6.5
11
7.0
33
7.5
99
8.0
2
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

37
Total Assays
195
Tested Compounds
1
Assay Types
Binding — 37 assays, 195 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 24 19 5.7
cell-based format 7 11 5.0
assay format 6 165 7.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine